Cite
HARVARD Citation
Watanabe, A. et al. (n.d.). BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells. Experimental dermatology. 22 (8), pp. 518-523. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Watanabe, A. et al. (n.d.). BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells. Experimental dermatology. 22 (8), pp. 518-523. [Online].